Fin Trust Capital Advisors, LLC Corcept Therapeutics Inc Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 1,339 shares of CORT stock, worth $68,824. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,339
Previous 1,771
24.39%
Holding current value
$68,824
Previous $57,000
7.02%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$850 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$514 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$425 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$335 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$196 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...